Where to Inject Ozempic for Weight Loss: Injection Sites Explained

Step 1: Choose one of the three approved sites

Semaglutide injections (whether Wegovy or Ozempic) are given subcutaneously, meaning just beneath the skin into fatty tissue, not into muscle or a vein. The three sites the manufacturer and clinical guidance endorse are the same ones used for most subcutaneous injections: the abdomen, the front of the thigh, and the outer upper arm.

The abdomen is the most commonly chosen area. Aim for the soft fatty tissue around the stomach, staying at least five centimetres away from the navel to avoid the denser tissue there. The front of the thigh works well when you are sitting, because the muscle relaxes and the overlying tissue is easier to pinch. The outer upper arm is convenient if someone else is giving the injection, but harder to administer to yourself because you need a firm, steady pinch with one hand while injecting with the other.

If you want to understand more about how the medicine acts once it reaches the tissue, the mechanism behind semaglutide's weight-loss effect is worth reading before your first dose. For broader context on how often the injection fits into a weekly routine, the dosing frequency page covers the schedule in plain terms.

The NHS medicines guidance on semaglutide confirms these three sites and notes that the pen should never be injected into a vein or muscle. NHS guidance on semaglutide is the clearest patient-level starting point if you want the full clinical picture.

Step 2: Prepare the site properly

Preparation takes less than a minute and makes a real difference. Wipe the skin with a fresh alcohol swab and let it air-dry completely, injecting through wet skin stings more and risks introducing a trace of alcohol into the tissue. Check visually for any bruising, redness, hardness or scarring from previous injections. If you find any, move elsewhere in the same body area or switch to a different site entirely for this week.

Pinch a fold of skin lightly between thumb and forefinger. Insert the needle at the angle the pen's instructions specify (most pre-filled pens are designed for a 90-degree insertion with a skin fold). Press the injection button, hold it for the count the Patient Information Leaflet advises, then withdraw before releasing the pinch. A steady hand matters more than speed.

Keeping a box of alcohol swabs alongside your pen means the preparation habit stays automatic. One quick wipe and a dry wait is the whole routine.

The full step-by-step process (including needle attachment, priming and post-injection disposal) is covered in the detailed injection technique guide. That page is worth reading before your first injection, alongside the leaflet in the box.

Step 3: Rotate systematically and watch the skin

Using the same spot week after week leads to lipodystrophy: the fat cells under repeated injection trauma can harden, thin or form lumps. That thickened tissue absorbs medicine erratically, which can affect how well the treatment works, something most people do not realise until they mention it to their prescriber.

A simple rotation system prevents this. Within the abdomen, imagine a clock face around your navel and move one position clockwise each week. Within the thigh, alternate left and right. If you use the upper arm, keep a note of which side you used last. The specific spot within the site should also shift by two to three centimetres from the previous injection.

A quick checking habit: before each injection, run a fingertip over the skin at the planned site. Smooth means safe to use. Any lumpiness or unusual firmness is a signal to choose a different area and mention it at your next clinical review.

The guidance for Wegovy's injection sites follows the same principles, you can read more on the best sites for Wegovy injections if you are comparing the two or considering a switch. Both medicines share an identical subcutaneous delivery method, so the rotation logic transfers directly.

What is licensed for weight loss in the UK, and where nume fits in

Ozempic (semaglutide 0.5mg and 1mg) is approved in the UK for type 2 diabetes. It is not licensed for weight management. The medicine that carries a UK weight-loss licence is Wegovy, semaglutide at a higher maintenance dose of 2.4mg, or now up to 7.2mg following MHRA approval in early 2026. Mounjaro (tirzepatide), a dual GIP and GLP-1 receptor agonist made by Eli Lilly, holds the other weight-loss licence. If you arrived here because you are looking into weight-loss treatment, those are the two medicines a UK prescriber can legally authorise for that purpose. The MHRA's Yellow Card scheme is also where you can report anything unusual about any medicine you receive, including concerns about the source of supply.

The Ozempic and weight loss page goes into the licensing distinction in more detail if you want a fuller comparison. For an overview of all licensed options, the weight-loss treatment overview is a clear starting point. If you have questions about which option suits your circumstances, our prescribers are available, you can start a free consultation and a GPhC-registered prescriber will review your answers the same day.